Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

296 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection. AIDS Clinical Trials Group Team 291.
McArthur JC, Yiannoutsos C, Simpson DM, Adornato BT, Singer EJ, Hollander H, Marra C, Rubin M, Cohen BA, Tucker T, Navia BA, Schifitto G, Katzenstein D, Rask C, Zaborski L, Smith ME, Shriver S, Millar L, Clifford DB, Karalnik IJ. McArthur JC, et al. Among authors: clifford db. Neurology. 2000 Mar 14;54(5):1080-8. doi: 10.1212/wnl.54.5.1080. Neurology. 2000. PMID: 10720278 Clinical Trial.
Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathy.
Schifitto G, Yiannoutsos C, Simpson DM, Adornato BT, Singer EJ, Hollander H, Marra CM, Rubin M, Cohen BA, Tucker T, Koralnik IJ, Katzenstein D, Haidich B, Smith ME, Shriver S, Millar L, Clifford DB, McArthur JC; AIDS Clinical Trials Group Team 291. Schifitto G, et al. Among authors: clifford db. Neurology. 2001 Oct 9;57(7):1313-6. doi: 10.1212/wnl.57.7.1313. Neurology. 2001. PMID: 11591856 Clinical Trial.
Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy.
Polydefkis M, Yiannoutsos CT, Cohen BA, Hollander H, Schifitto G, Clifford DB, Simpson DM, Katzenstein D, Shriver S, Hauer P, Brown A, Haidich AB, Moo L, McArthur JC. Polydefkis M, et al. Among authors: clifford db. Neurology. 2002 Jan 8;58(1):115-9. doi: 10.1212/wnl.58.1.115. Neurology. 2002. PMID: 11781415
HIV neuropathy natural history cohort study: assessment measures and risk factors.
Simpson DM, Kitch D, Evans SR, McArthur JC, Asmuth DM, Cohen B, Goodkin K, Gerschenson M, So Y, Marra CM, Diaz-Arrastia R, Shriver S, Millar L, Clifford DB; ACTG A5117 Study Group. Simpson DM, et al. Among authors: clifford db. Neurology. 2006 Jun 13;66(11):1679-87. doi: 10.1212/01.wnl.0000218303.48113.5d. Neurology. 2006. PMID: 16769940 Clinical Trial.
A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment.
Schifitto G, Zhang J, Evans SR, Sacktor N, Simpson D, Millar LL, Hung VL, Miller EN, Smith E, Ellis RJ, Valcour V, Singer E, Marra CM, Kolson D, Weihe J, Remmel R, Katzenstein D, Clifford DB; ACTG A5090 Team. Schifitto G, et al. Among authors: clifford db. Neurology. 2007 Sep 25;69(13):1314-21. doi: 10.1212/01.wnl.0000268487.78753.0f. Epub 2007 Jul 25. Neurology. 2007. PMID: 17652642 Clinical Trial.
Selegiline and oxidative stress in HIV-associated cognitive impairment.
Schifitto G, Yiannoutsos CT, Ernst T, Navia BA, Nath A, Sacktor N, Anderson C, Marra CM, Clifford DB; ACTG 5114 Team. Schifitto G, et al. Among authors: clifford db. Neurology. 2009 Dec 8;73(23):1975-81. doi: 10.1212/WNL.0b013e3181c51a48. Epub 2009 Nov 4. Neurology. 2009. PMID: 19890073 Free PMC article. Clinical Trial.
296 results